Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 19, Issue 6, 2012, Pages 674-684

  Yang, Yongping ^a   Wang, Chunping ^a   Lu, Yinying ^a   Bai, Wenlin ^a   An, Linjing ^a   Qu, Jianhui ^a   Gao, Xudong ^a   Chen, Yan ^a   Zhou, Lin ^a   Wu, Yu ^a   Feng, Yongyi ^a   Zhang, Minna ^a   Chang, Xiujuan ^a   Lv, Jiyun ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

Cryoablation; Efficacy; Hepatocellular carcinoma; Safety; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ARGON; ATROPINE; BICARBONATE; BILIRUBIN; HELIUM; SORAFENIB;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; BILIRUBIN BLOOD LEVEL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHILL; CLINICAL TRIAL; COLD INJURY; CRYOABLATION; CRYOSHOCK SYNDROME; DEATH; DISEASE SEVERITY; FEMALE; FEVER; FOLLOW UP; HEMATOTHORAX; HUMAN; INTESTINE FISTULA; KIDNEY INJURY; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FAILURE; LIVER HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN; PATIENT SAFETY; PLEURA EFFUSION; PNEUMOTHORAX; SHOCK; STOMACH HEMORRHAGE; SURVIVAL TIME; TACHYCARDIA; TACHYPNEA; THROMBOCYTE COUNT; TREATMENT INDICATION; TUMOR LOCALIZATION; TUMOR VOLUME; ULTRASOUND GUIDED PERCUTANEOUS ARGON HELIUM CRYOABLATION;

ADULT; AGED; ARGON; CARCINOMA, HEPATOCELLULAR; CHINA; CRYOSURGERY; FEMALE; FOLLOW-UP STUDIES; HELIUM; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PATIENT SELECTION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84872179078     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-011-0490-6     Document Type: Article

References (23)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-43.
2. Tang ZY. Perspective of clinical oncology from the viewpoint of liver cancer studies. Tumor (China). 2009;29:1-4.
3. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg. 2001;234:63-70.
4. Orlacchio A, Bazzocchi G, Pastorelli D, Bolacchi F, Angelico M, Almerighi C, et al. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. Cardiovasc Intervent Radiol. 2008;31:587-94.
5. Atwell TD, Farrell MA, Callstrom MR, Charboneau JW, Leibovich BC, Patterson DE, et al. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. Radiology. 2007;243:276-83.
6. Lee FT Jr, Mahvi DM, Chosy SG, Onik GM, Wong WS, Littrup PJ, et al. Hepatic cryosurgery with intraoperative US guidance. Radiology. 1997;202:624-32.
7. Shock SA, Laeseke PF, Sampson LA, Lewis WD, Winter TC 3rd, Fine JP, et al. Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. Radiology. 2005;236:125-31.
8. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329-38.
9. Wang C, Lu Y, Chen Y, Feng Y, An L, Wang X, et al. Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study. Clin Exp Metastasis. 2009;26:839-48.
10. Zuro LM, Staren ED. Cryosurgical ablation of unresectable hepatic tumors. AORN J. 1996;64(231-236):239-44.
11. Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 2009;58:1-11.
12. Osada S, Imai H, Tomita H, Tokuyama Y, Okumura N, Matsuhashi N, et al. Serum cytokine levels in response to hepatic cryoablation. J Surg Oncol. 2007;95:491-8. (Pubitemid 46709393)
13. Shimizu T, Sakuhara Y, Abo D, Hasegawa Y, Kodama Y, Endo H, et al. Outcome of MR-guided percutaneous cryoablation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16: 816-23.
14. Nagata Y, Hiraoka M, Nishimura Y, Masunaga S, Mitumori M, Okuno Y, et al. Clinical results of radiofrequency hyperthermia for malignant liver tumors. Int J Radiat Oncol Biol Phys. 1997;38:359-65.
15. Helling TS. Realistic expectations for cryoablation of liver tumors. J Hepatobiliary Pancreat Surg. 2000;7:510.
16. Hinshaw JL, Lee FT Jr. Cryoablation for liver cancer. Tech Vasc Interv Radiol. 2007;10:47-57.
17. Kerkar S, Carlin AM, Sohn RL, Steffes C, Tyburski J, Littrup P, et al. Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors. Surgery. 2004;136:770-9. (Pubitemid 39311302)
18. Xu KC, Niu LZ, Zhou Q, Hu YZ, Guo DH, Liu ZP, et al. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol. 2009;15:3664-9.
19. Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA. 2008;299:1669-77.
20. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 2003;37:429-42.
21. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S179-88.
22. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg. 1999;23:109-13.
23. Ng KK, Lam CM, Poon RT, Shek TW, To JY, Wo YH, et al. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model. Ann Surg Oncol. 2004;11:650-7. (Pubitemid 40486699)